Hanmi unveiled its latest findings at 2024 ObesityWeek, an annual obesity-focused conference held in San Antonio, Texas, from November 3 to 6.
News
- Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1 ...
- Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity ...
... San Antonio, Texas. Highlights from the presentation: The objective of the meta-analysis was to determine the effects of enobosarm on body ...
- Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of ...
("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology ... Initial Phase 1 data was presented at the San Antonio Breast Cancer Symposium in December ...
- At this year's ObesityWeek, GLP-1s aren't the only talk of the town - Endpoints News
SAN ANTONIO — As the GLP-1 class has taken over in recent years, a once-fringe conference has come into the spotlight for the biopharma industry.
- Demand for San Antonio flights hits record pace - The Business Journals
Demand for San Antonio flights hits record pace. Heightened traffic has underscored the need to advance the city's $2.5 billion airport expansion plan ...